GSA Capital Partners’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58K | Buy |
+71,378
| New | +$58K | ﹤0.01% | 1655 |
|
|
2023
Q4 | – | Sell |
-70,583
| Closed | -$218K | – | 1836 |
|
|
2023
Q3 | $218K | Sell |
70,583
-2,251
| -3% | -$6.95K | 0.02% | 1246 |
|
|
2023
Q2 | $328K | Buy |
72,834
+25,220
| +53% | +$114K | 0.03% | 1000 |
|
|
2023
Q1 | $271K | Sell |
47,614
-187
| -0.4% | -$1.06K | 0.03% | 1084 |
|
|
2022
Q4 | $289K | Sell |
47,801
-6,372
| -12% | -$38.5K | 0.04% | 952 |
|
|
2022
Q3 | $358K | Buy |
54,173
+17,547
| +48% | +$116K | 0.05% | 816 |
|
|
2022
Q2 | $191K | Buy |
36,626
+13,425
| +58% | +$70K | 0.03% | 1083 |
|
|
2022
Q1 | $160K | Buy |
+23,201
| New | +$160K | 0.02% | 1222 |
|